Related Experiment Video

Updated: May 20, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated

    Cell Stem Cell
    |July 4, 2012
    PubMed

    Insights

    Huntington's disease (HD) research advances with new patient-derived stem cells. These induced pluripotent stem cells (iPSCs) reveal disease mechanisms and offer a platform for therapeutic screening.

    Area of Science:

    • Neuroscience
    • Genetics
    • Stem Cell Biology

    Background:

    • Huntington's disease (HD) is a neurodegenerative disorder caused by expanded CAG trinucleotide repeats.
    • This genetic defect leads to neuronal dysfunction and death, impacting families worldwide.

    Purpose of the Study:

    • To generate and characterize induced pluripotent stem cell (iPSC) lines from HD patients and controls.
    • To identify disease-specific molecular and cellular phenotypes using these iPSC models.
    • To establish a human stem cell platform for therapeutic development in HD.

    Main Methods:

    • Generation and characterization of 14 iPSC lines from HD patients and healthy controls.
    • Microarray profiling to identify gene expression patterns associated with CAG repeat expansion.
    • Differentiation of iPSCs into neural cells for functional assays (electrophysiology, metabolism, cell death).
    • Assessment of cellular vulnerability to stressors and growth factor withdrawal.

    Main Results:

    • Distinct gene expression patterns were identified in HD patient iPSC lines, differentiating them from controls and correlating with disease onset.
    • Differentiated HD neural cells exhibited disease-associated changes in electrophysiology, metabolism, and cell adhesion.
    • HD neural cells with longer CAG repeat expansions showed increased vulnerability to cellular stressors and BDNF withdrawal, indicating a dose-dependent effect.

    Conclusions:

    • The generated HD iPSC collection is a valuable resource for understanding disease mechanisms.
    • These iPSC models provide a human-based platform for screening and developing novel therapeutics for Huntington's disease.

    More Related Videos

    Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

    Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

    Published on: February 27, 2018

    Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells09:11

    Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

    Published on: January 28, 2015

    Related Concept Videos

    Huntington Disease l: Introduction01:21

    Huntington Disease l: Introduction

    Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
    EPS and iPS Cells in Disease Research01:21

    EPS and iPS Cells in Disease Research

    Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
    Induced Pluripotent Stem Cells01:06

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
    Somatic cells are...
    Induced Pluripotent Stem Cells01:13

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
    iPS Cell Differentiation01:22

    iPS Cell Differentiation

    The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
    Chromatin Modification in iPS Cells01:32

    Chromatin Modification in iPS Cells

    Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
    Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...